Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quanwu Zhang

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Prevention of Alzheimer'S Disease|February 27, 2025
American's overall and equity-based societal valuation of a disease-modifying Alzheimer's treatment: Results from a discrete choice experimentFrancisco Perez-Arce, Jeremy Burke, Lila Rabinovich, et al.
Medical Care|May 15, 2007
Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetesQuanwu Zhang, Monika Safford, Donald Miller, et al.
Neurology and Therapy|April 3, 2023
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD TrialAmir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, et al.
Journal of Cancer Research and Clinical Oncology|May 24, 2020
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinomaYuanbo Cui, Ming Yan, Chunyan Zhang, et al.
Alzheimer Disease and Associated Disorders|May 17, 2024
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United StatesPeter Morin, Byron J Aguilar, Dan Berlowitz, et al.
Neurology and Therapy|March 17, 2023
Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, et al.
Neurology and Therapy|May 31, 2023
Estimating Transition Probabilities Across the Alzheimer's Disease Continuum Using a Nationally Representative Real-World Database in the United StatesAmir Abbas Tahami Monfared, Shuai Fu, Noemi Hummel, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2024
Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad SurveysAmir Abbas Tahami Monfared, Artak Khachatryan, Noemi Hummel, et al.
Journal of Medical Economics|May 17, 2019
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung diseaseTheodore K Marras, Mehdi Mirsaeidi, Christopher Vinnard, et al.
Clinical Therapeutics|July 2, 2011
Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial designPhilip A Levin, Quanwu Zhang, James H Mersey, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Prevention of Alzheimer'S Disease|February 27, 2025
American's overall and equity-based societal valuation of a disease-modifying Alzheimer's treatment: Results from a discrete choice experimentFrancisco Perez-Arce, Jeremy Burke, Lila Rabinovich, et al.
Medical Care|May 15, 2007
Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetesQuanwu Zhang, Monika Safford, Donald Miller, et al.
Neurology and Therapy|April 3, 2023
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD TrialAmir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, et al.
Journal of Cancer Research and Clinical Oncology|May 24, 2020
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinomaYuanbo Cui, Ming Yan, Chunyan Zhang, et al.
Alzheimer Disease and Associated Disorders|May 17, 2024
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United StatesPeter Morin, Byron J Aguilar, Dan Berlowitz, et al.
Neurology and Therapy|March 17, 2023
Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, et al.
Neurology and Therapy|May 31, 2023
Estimating Transition Probabilities Across the Alzheimer's Disease Continuum Using a Nationally Representative Real-World Database in the United StatesAmir Abbas Tahami Monfared, Shuai Fu, Noemi Hummel, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2024
Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad SurveysAmir Abbas Tahami Monfared, Artak Khachatryan, Noemi Hummel, et al.
Journal of Medical Economics|May 17, 2019
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung diseaseTheodore K Marras, Mehdi Mirsaeidi, Christopher Vinnard, et al.
Clinical Therapeutics|July 2, 2011
Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial designPhilip A Levin, Quanwu Zhang, James H Mersey, et al.
Pageof 7